Santen Pharmaceutical Co., Ltd. (SNPHY)
12.03
+0.31
(+2.67%)
USD |
OTCM |
May 29, 16:00
Santen Pharmaceutical EPS Diluted (Quarterly) : 0.3043 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | -0.0496 |
| Daiichi Sankyo Co., Ltd. | 0.1472 |
| Eisai Co., Ltd. | -0.0184 |
| Chugai Pharmaceutical Co., Ltd. | 0.2235 |
| Ono Pharmaceutical Co., Ltd. | 0.0036 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 99.13M |
| Revenue (Quarterly) | 515.37M |
| Total Expenses (Quarterly) | 416.30M |
| Enterprise Value | 3.355B |
| Gross Profit Margin (Quarterly) | 61.43% |
| Profit Margin (Quarterly) | 19.24% |
| Earnings Yield | 6.21% |
| Operating Earnings Yield | 7.41% |